Skip to content

Released Aug 15, 2016, during market hours

10-Q filed Aug 15, 2016, 46 days after period end · 0001213900-16-015974

Q2 2016 · 10-Q
Revenue—
Net Income-$4.39MN/M vs Q2 2015N/M vs Q1 2016
EPS Diluted-$6.30— vs Q2 2015N/M vs Q1 2016
Operating Income-$4,377,433N/M
Operating Cash Flowderived-$2,950N/M
Free Cash Flowderived-$5,798—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2016Q2 2015Q2 2014Q2 2013
Net Income-$4.39M-$7.27K-$6.95K-$6.75K
EPS Diluted-$6.30$0.00$0.00$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR